Your browser doesn't support javascript.
loading
Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.
Peter, Stefanie; Bultinck, Jennyfer; Myant, Kevin; Jaenicke, Laura A; Walz, Susanne; Müller, Judith; Gmachl, Michael; Treu, Matthias; Boehmelt, Guido; Ade, Carsten P; Schmitz, Werner; Wiegering, Armin; Otto, Christoph; Popov, Nikita; Sansom, Owen; Kraut, Norbert; Eilers, Martin.
Afiliação
  • Peter S; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
  • Bultinck J; Cytokine Receptor Lab, Department of Biochemistry, Ghent University, Ghent, Belgium.
  • Myant K; CRUK Beatson Institute, Glasgow, UK.
  • Jaenicke LA; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
  • Walz S; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
  • Müller J; Department of Molecular Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Gmachl M; Department Lead Discovery, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Treu M; Department Lead Discovery, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Boehmelt G; Department Lead Discovery, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Ade CP; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
  • Schmitz W; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany.
  • Wiegering A; Department of General, Visceral, Vascular and Paediatric Surgery, University Hospital Würzburg, Würzburg, Germany.
  • Otto C; Department of General, Visceral, Vascular and Paediatric Surgery, University Hospital Würzburg, Würzburg, Germany.
  • Popov N; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany.
  • Sansom O; CRUK Beatson Institute, Glasgow, UK.
  • Kraut N; Department Lead Discovery, Boehringer Ingelheim RCV GmbH & Co KG, Vienna, Austria.
  • Eilers M; Theodor Boveri Institute, Biocenter, University of Würzburg, Würzburg, Germany Comprehensive Cancer Center Mainfranken, University of Würzburg, Würzburg, Germany martin.eilers@biozentrum.uni-wuerzburg.de.
EMBO Mol Med ; 6(12): 1525-41, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25253726
ABSTRACT
Deregulated expression of MYC is a driver of colorectal carcinogenesis, necessitating novel strategies to inhibit MYC function. The ubiquitin ligase HUWE1 (HECTH9, ARF-BP1, MULE) associates with both MYC and the MYC-associated protein MIZ1. We show here that HUWE1 is required for growth of colorectal cancer cells in culture and in orthotopic xenograft models. Using high-throughput screening, we identify small molecule inhibitors of HUWE1, which inhibit MYC-dependent transactivation in colorectal cancer cells, but not in stem and normal colon epithelial cells. Inhibition of HUWE1 stabilizes MIZ1. MIZ1 globally accumulates on MYC target genes and contributes to repression of MYC-activated target genes upon HUWE1 inhibition. Our data show that transcriptional activation by MYC in colon cancer cells requires the continuous degradation of MIZ1 and identify a novel principle that allows for inhibition of MYC function in tumor cells.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteína Oncogênica p55(v-myc) / Ubiquitina-Proteína Ligases / Bibliotecas de Moléculas Pequenas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteína Oncogênica p55(v-myc) / Ubiquitina-Proteína Ligases / Bibliotecas de Moléculas Pequenas Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article